| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |